SCHEMBL4471168

SCHEMBL4471168

CC(=O)NC(=O)C(C#N)=CC=Cc1ccc(O)c(O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.67
EGFR P00533 12/20 0.49
DNM1 Q05193 6/20 0.49
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
HPGD P15428 4/20 0.47
LMNA P02545 4/20 0.47
MEN1 O00255 3/20 0.47
TP53 P04637 3/20 0.47
KMT2A Q03164 3/20 0.47
HSD17B10 Q99714 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
CYP3A4 P08684 2/20 0.47
ALOX15 P16050 2/20 0.47
ALOX12 P18054 2/20 0.47
NFKB1 P19838 2/20 0.47
MAPK1 P28482 2/20 0.47
BLM P54132 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471166 1.00 MAOB (0.67) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL13678178 0.87 KLK7 (0.53) MAOBEGFRKDM4EALDH1A1MAPT
SCHEMBL13678204 0.85 LMNA (0.52) MAOBKDM4EALDH1A1MAPTHPGD
SCHEMBL13678104 0.85 MAOB (0.63) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL13678112 0.85 MAPT (0.50) MAOBEGFRKDM4EALDH1A1MAPT
SCHEMBL5159630 0.84 MAOB (0.53) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL5159642 0.84 MAOB (0.53) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL4490417 0.83 MAOB (0.59) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL4490410 0.83 MAOB (0.59) MAOBEGFRDNM1KDM4EALDH1A1
SCHEMBL13678199 0.83 LMNA (0.46) MAOBEGFRKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAOB 3511/4885EGFR 1713/4885DNM1 2951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.